Our Leadership

Board of Directors

Angela-B-195x244x-1

Angela Babaev

D.N.P., C.N.S., M.S.N.

Chair
Queens, NY

Currently serving as the Assistant Vice President for Education and Nursing Recruitment at SBH Bronx Health System, Dr. Babaev is dedicated to promoting excellence in patient care through the development of nursing staff, evidence-based nursing practices, and an environment that continually redefines quality patient care. In her 30+ years of experience, Dr. Babaev has overseen the educational, managerial, and financial operations for a nursing staff of 1,500, created an innovative nurse recruitment and retention program, led workshops locally and internationally, served as a Lecturer of Program for International Nurses, and served as an advocate and board member for NAMI-QN. Today, she serves as 2021 president-elect of the Greater New York Organization of Nurse Executives and Leaders.

Linda195x244-3

Linda L. Mimms

M.A.

Vice Chair
San Diego, CA

Linda has been an advocate for reform in public policy, law, insurance and treatment protocols for people living with serious neurobiological brain disorders for more than 12 years. She began her career as a lobbyist on Capitol Hill for Xerox Corporation, moved on to working for the U.S. State Department in Boston and then as U.S. Sen. Alan J. Dixon’s Government Affairs/Legislative Analyst Assistant in Chicago and Washington, D.C. As the creator and manager of the Public Relations and Employee Communications Department for Quill Corporation, Linda authored and edited seven informational books and manuals on business productivity, with more than 100 articles and business tips published nationally in newspapers, magazines, newsletters and catalogs. She has been a featured speaker at several national meetings, including the Capitol Hill briefing “People With Schizophrenia Face Severe Treatment Barriers: Regulatory, Policy Solutions Urgently Needed To Address Inequity,” in May 2023; the Public Policy Panel at the Schizophrenia & Psychosis Action Alliance 2020 symposium; The Hill 2021 national event “The New Role of Telehealth;” and Center Forward’s 2022 Capitol Hill Healthcare Summit. Linda’s podcasts, commentaries and editorials addressing the lack of a continuum of care and criminalization of those with serious brain disorders, one of the greatest injustices of our time, have been published nationally and locally.

Linda earned an M.A. in Public Policy from Duke University and a B.A. in Anthropology from Lawrence University. She is Vice Chair of S&PAA and a member of the National Alliance on Mental Illness (NAMI), the California Coalition for CARE/Grave Disability Workgroup and the National Shattering Silence Coalition (NSSC). She serves on Lawrence University’s President’s Advisory Council. In 2020, she established the Lawrence Fund for Serious Mental Illness Advocacy Internships to give students the opportunity to learn about serious brain diseases, their criminalization and how to build solutions for better access to medical treatment with supportive care and housing.

Kurt-T195x244-1-(1)_web5

Holly Krasa

M.Sc.

Committee Chair
Washington, DC

Holly is CEO and Managing Director of Blue Persimmon Group — a non-profit advocacy and life sciences consulting firm. Holly is a global medical product development leader and health outcomes researcher working to incorporate lived experience in new treatment approvals, system change and access to evidence-based care. She has successfully developed clinical outcome measures, biomarkers, first-in-disease and first-of-kind treatments across brain, heart, kidney and rare diseases. Holly received a Bachelor of Science in Biology from the University of Michigan and a Master of Science in Neurobiology and Physiology from Northwestern University.

theresafrangiosa

Theresa Frangiosa

M.B.A.

Secretary
Royersford, PA

Terry Frangiosa partners with clients in the pharmaceutical and healthcare industries, helping companies bridge between patient experience and commercialization opportunities. She served in executive roles throughout the pharmaceutical industry for more than 25 years before starting her own healthcare strategic consulting firm, an organization she led for a decade. Terry is now a Senior Director for Faegre Drinker Consulting. She has long-standing advocacy experience, previously serving on the boards of non-profit organizations such as Living Beyond Breast Cancer, Orion Bionetworks, Early Signal, Cohen Veterans Bioscience and the Schizophrenia & Psychosis Action Alliance. She also is the Program Director for the Alzheimer’s Disease Patient and Caregiver Engagement (AD PACE®) Initiative and the Lead Investigator for UsAgainstAlzheimer’s A-LIST® What Matters Most Research Series.

anthonybrown

Anthony Brown

B.S.N., P.H.N., R.N.

Board Member
Anaheim, CA

Anthony is the founder and director of Coordinating & Assisting Recovery Environments located in Anaheim, CA. Since 1999, Anthony’s passion has been focused on providing specialized treatment for individuals who suffer with a mental illness combined with a substance use disorder. After graduation in 2004, Anthony launched his career in Southern California where he began to specialize in co-occurring disorders. This eventually led him into a four-year partnership with a prominent treatment center where he developed and directed a long-term residential treatment model for this specialized population. In 2013, Anthony introduced Coordinating & Assisting Recovery Environments (C.A.R.E.) as a community-based recovery program. He is the author of the life changing book “From Park Bench to Park Avenue.” Anthony is a graduate of California State University, Fullerton, where he received his B.S. in Nursing. Anthony has received numerous awards and certificates in the field of Addiction Counseling, Anger Management, and Dual Diagnoses.

Marina Dorotheo

Marina Dorotheo, M.S.​

M.Ed.

Board Member
Arlington, VA

Marina has extensive experience in bringing novel digital solutions to the market, specific to brain health and cardiometabolic conditions. Marina currently serves as Chief Marketing Officer at Welldoc, a digital health company, focused on integrating AI driven digital chronic care into health care models.   Previously Marina served in commercial leadership roles at Otsuka Pharmaceutical, Inc., where she ran several innovation programs focused on schizophrenia and other brain disorders.  There, she led the commercialization of the first digital medicine approved by the FDA, as well as a digital health care coordination program in collaboration with IBM Watson, Judge Steve Leifman, and the Miami-Dade County Behavioral Health ecosystem.   She received a Bachelor of Science degree in Biochemistry from Georgia Institute of Technology and a Master of Science degree in Biotechnology from Johns Hopkins University.

mindygreiling

Mindy Greiling

M.Ed.

Board Member
Roseville, MN

Mindy Greiling served in the Minnesota House of Representatives for 20 years, where she initiated the first state bipartisan mental health caucus after her son was diagnosed with schizophrenia. She served on state and national NAMI boards and is the immediate past president of NAMI Ramsey County. She co-chairs NAMI Ramsey County’s advocacy for Clubhouse International and is leading advocacy for more affordable housing that fits people with serious mental illnesses. Greiling’s memoir, Fix What You Can: Schizophrenia and a Lawmaker’s Fight for Her Son, was published in 2020, and she co-hosts the podcast Schizophrenia: Three Moms in the Trenches.

Matcheri Keshavan

Matcheri Keshavan

M.D.

Committee Co-Chair
Boston, MA

Dr. Keshavan is the Stanley Cobb Professor of Psychiatry at Harvard Medical School, where he is the Academic Head of Psychiatry at the Beth Israel Deaconess Medical Center. He joined the faculty of the Beth Israel Deaconess Medical Center Department of Psychiatry and the Massachusetts Mental Health Center in 2008. His work focuses on neurobiological models of schizophrenia and on the development and implementation of early interventions with biopsychosocial treatment strategies. He is the editor of Schizophrenia Research, the official journal of the Schizophrenia International Research Society.

Rob-L195x244

Robert Laitman

M.D.

Board Member
Bedford, NY

Dr. Laitman is a private practice physician in Bronx, New York. He specializes in internal medicine, nephrology, geriatrics, and the optimal management of clozapine. He loves being a physician and involves himself in the total care of his patients. When his son was diagnosed with schizophrenia in 2006, Robert expanded his practice and became an expert on the treatment of psychosis spectrum disorders and began to specialize in the optimal management of clozapine.

Tim-Murphy-1-240x300

Tim Murphy

Ph.D.

Board Member
Mt. Lebanon, PA

Dr. Murphy’s professional work includes over 40 years in healthcare, government service, military, education, and media. He was the only mental health professional in the U.S. House of Representatives with this unique background. Recognized as the national leader in mental health reform, his multi-year investigation into federal problems with mental health policy culminated with a comprehensive bill, Helping Families in Mental Health Crisis Act, praised as the most substantial mental health reform in over half a century. The bill passed the House of Representatives 422-2 and was amended into the 21st Century Cures Act signed into law by President Obama in December 2016.

mary-pallafox195x244

Mary Palafox

R.N.

Board Member
Orange County, CA

Mary is a registered nurse of 35 years with experience in nursing administration, supervision, and patient care coordination for inpatient and ambulatory care services. She’s known for her innovative and creative abilities in developing systems of practice that are easily managed by a wide variety of medical personnel. Her journey into the mental health system began when her son was diagnosed with schizophrenia. Since then, Mary has remained a devoted advocate on the local, state, and national levels for healthcare integration, crisis intervention, and the classification of schizophrenia as a neurological brain disorder.

Kurt-T195x244-1-(1)_web3

Kurt A. Talbot

M.B.A.

Board Member
Boerne, TX

Kurt is an experienced investor with deep expertise in problem-solving and investment prioritization for companies and private energy projects globally. He is the co-founder of EIG Global Energy Partners and served as the Chief Investment Officer and Chair of the Environmental Social Governance Committee. While at Goldman Sachs, he founded its oil and gas direct investment team in Houston. He has a B.S. in Petroleum Engineering from Louisiana State University and holds an M.B.A. from Texas A&M University.

joelwhite

Joel White

B.S.

Board Member
McLean, VA

Joel founded Horizon Government Affairs in 2007 and is a veteran of Capitol Hill who served as staff director for the Ways and Means Health Subcommittee. He also is president of the Council for Affordable Health Coverage, whose mission is to lower health costs for all Americans. He founded a service organization called Arlington Bridge Builders, which serves 20,000 low income food- and housing-insecure people in his community. He is on the board of directors of the Samaritan Inns, one of the largest homeless treatment and housing shelters in Washington, D.C. Joel spent 12 years on Capitol Hill as professional staff, where he helped enact nine laws, including the 2002 Trade Act, the 2003 law that established the Medicare prescription drug benefit and Health Savings Accounts, the 2005 Deficit Reduction Act and the 2006 Tax Reform and Health Care Act. Joel is co-author of the book Facts and Figures on Government Finance and holds a B.S. in Economics from the American University.

michaelwolfe

Michael Wolfe

B.B.A.

Board Member
Doylestown, PA

Mike spent nearly 37 years at Johnson & Johnson in executive management positions with a strong focus on patient advocacy leadership responsibilities across brain health and neuroscience.  He held leadership roles in sales, sales management, marketing, payer, policy and advocacy (advocacy group types: patient, professional and trade organizations), and built and led several innovative and successful internal and external coalitions.  He also held commercial, Medicaid and state mental healthcare system responsibilities across New York and New England. Mike obtained his BBA in Marketing from East Tennessee State University.

Scientific Advisory Committee

The Scientific Advisory Committee provides strategic guidance and direction for S&PAA’s global programming on:

  • Research projects, specifically our research strategic plan development and execution.
  • Scientific education, specifically our education strategic plan development and execution.
  • Scientific communication, including contributing to the dissemination of scientific findings relevant to S&PAA’s mission and providing expertise on involvement in media or legal affairs.
Kurt-T195x244-1-(1)_web5

Holly Krasa

M.Sc.

CEO and Managing Director, Blue Persimmon Group
 
Committee Chair
Matcheri Keshavan

Matcheri Keshavan

M.D.

Stanley Cobb Professor of Psychiatry, Harvard Medical School Head of Psychiatry, Beth Israel Deaconess Medical Center

Committee Co-Chair

Kristen-Choi-PhD_web

Kristen R. Choi

Ph.D., PMHNP-BC, FAAN

Assistant Professor, School of Nursing University of California, Los Angeles

BlankProfile

Lynn DeLisi

M.D.

Attending Psychiatrist and Professor, Cambridge Health Alliance Professor of Psychiatry, Harvard Medical School Editor-in-Chief, Psychiatry Research

Koyanagi-Headshot_web

Chad Koyanagi

M.D.

Medical Director, Crisis Continuum and Medicaid Services Hawaii Department of Health, Adult Mental Health Division

Gooding-Headshot-Final_web

Diane Gooding

Ph.D.

Full Professor of Psychology, Psychiatry and Medicine University of Wisconsin-Madison

Phil-Harvey-Headshot_web

Phil Harvey

Ph.D.

Leonard M. Miller Professor of Psychiatry, Vice Chair for Research and Director of the Division of Psychology, University of Miami Miller School of Medicine

Senior Health Research Scientist, Bruce W. Carter VA Medical Center 

Dolores-Malaspina-Headshot-Final_web

Dolores Malaspina

M.D.

Jason-Shafrin-PhD_web

Jason Shafrin

Ph.D.

Senior Managing Director, Center for Healthcare Economics and Policy, FTI Consulting Adjunct Professor, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California

Michael-Townsend_Web

Michael Townsend

M.A., L.C.S.W.

Peer Advisory Committee

The Peer Advisory Committee draws from each member’s lived experience to provide insights and guidance on programming, content and services.

Lisa-Guardiola-Headshot-2024_web

Lisa Guardiola

M.H.P., R.S.S.

Illinois

Paulie-Benjamin_web

Paulie VonEdWærd-Benjamin

Michigan

Angela-Smith_web

Angela Smith

California

Zuhara-Namibia_web

Zuharalove Namibia

South Carolina

CEO

Gordon Lavigne

M.Ed.

Alexandria, VA

Gordon joined Schizophrenia & Psychosis Action Alliance as CEO in November 2020. He previously served as Executive Vice President of Operations since September 2018.

Before joining the organization, Gordon held executive management positions with leading nonprofits including the Alzheimer’s Association, the ALS Association, and Autism Society of America coordinating and executing strategies to accelerate organizational growth. 

Gordon earned a B.S. in Psychology from Lewis & Clark College and a Master of Education degree from the University of Vermont.

Director of Operations

Marissa Shepherd

Cuyahoga Falls, OH

Marissa joined the Schizophrenia & Psychosis Action Alliance in March 2023. Previously, she was the founding Executive Director of the Northeast Ohio Medical University Health Care clinic and Center for Integrated Primary and Mental Health Care. She has a LEAN/Six-Sigma Green Belt and more than a decade of experience in management, operations, finance and grant accountancy for nonprofit organizations. Her career and interests are focused on reducing healthcare disparities and advancement of marginalized individuals and groups.

Marissa is a Certified Public Accountant, and earned a Master’s degree in Professional Accountancy and a Bachelor’s degree in Business Administration from Stephen F. Austin State University in Texas.   

Director of Research and Scientific Affairs

Arundati (Arun) Nagendra

Ph.D.

Boston, MA

Arun joined the Schizophrenia & Psychosis Action Alliance in May 2023. She is spearheading the development and execution of a scientific strategic plan that will leverage research projects and science communication to better serve the needs of those with lived experience of schizophrenia and related disorders.

Arun earned her undergraduate degree from Northwestern University and her doctorate in clinical psychology from the University of North Carolina at Chapel Hill. She completed her clinical fellowship at Yale University’s School of Medicine, and her postdoctoral fellowship at Massachusetts General Hospital/Harvard Medical School.

AdobeStock_117959885_web

We believe in recovery and a cure for schizophrenia.
Join us on this journey today.

Thanks to a generous donor, your gift will be matched, up to $25,000, and your impact doubled to help S&PAA’s critical work.

We believe in recovery and a cure for schizophrenia. Donate today.